Should not be administered by SC or IM route. Hypersensitivity reactions. Patients w/ known allergies including drug allergies, including patients w/ history of severe asthma, eczema or other atopic allergy; patients w/ immune or inflammatory conditions (eg, SLE, RA). Hypophosphataemia in patients w/ existing risk factors & after prolonged exposure to high-dose IV Fe. Avoid in patients w/ hepatic dysfunction where Fe overload is a precipitating factor, ie, Porphyria Cutanae Tarda (PCT); carefully monitor Fe status. Acute or chronic infection, asthma, eczema or atopic allergies. Discontinue treatment in patients w/ ongoing bacteraemia; paravenous leakage. Patients on Na-controlled diet. Pregnancy & lactation. Childn.